KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Operating Expenses (2016 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Operating Expenses for 18 consecutive years, with $898.5 million as the latest value for Q1 2026.

  • For Q1 2026, Operating Expenses rose 55.97% year-over-year to $898.5 million; the TTM value through Mar 2026 reached $3.5 billion, up 43.49%, while the annual FY2025 figure was $3.2 billion, 32.46% up from the prior year.
  • Operating Expenses hit $898.5 million in Q1 2026 for Alnylam Pharmaceuticals, down from $965.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $965.3 million in Q4 2025 and bottomed at $360.0 million in Q1 2022.
  • Average Operating Expenses over 5 years is $615.8 million, with a median of $556.1 million recorded in 2023.
  • Year-over-year, Operating Expenses decreased 1.05% in 2022 and then soared 55.97% in 2026.
  • Alnylam Pharmaceuticals' Operating Expenses stood at $523.6 million in 2022, then rose by 6.2% to $556.1 million in 2023, then increased by 25.57% to $698.3 million in 2024, then soared by 38.23% to $965.3 million in 2025, then dropped by 6.92% to $898.5 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $898.5 million, $965.3 million, and $881.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.